ASLN ASLAN Pharmaceuticals Limited ADRs

ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$2.65  +0.01 (0.38%)
As of 05/13/2021 11:20:08 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Singapore
Country of incorporation:  
IPO date:  05/04/2018
Outstanding shares:  37,990,994
Average volume:  426,707
Market cap:   $107,514,513
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    04522R101
ISIN:        US04522R1014
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   6.78
PS ratio:   0.00
Return on equity:   152.90%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy